Mexico stocks higher at close of trade; S&P/BMV IPC up 0.12%

Investing.com – Canada stocks were higher after the close on Thursday, as gains in the Healthcare, IT and Financials sectors led shares higher.

At the close in Toronto, the S&P/TSX Composite added 1.02% to hit a new all time high.

The best performers of the session on the S&P/TSX Composite were Descartes Systems Group Inc (TSX:DSG), which rose 14.37% or 16.64 points to trade at 132.45 at the close. Meanwhile, EQB Inc (TSX:EQB) added 12.85% or 11.16 points to end at 98.01 and MDA Ltd (TSX:MDA) was up 9.79% or 2.26 points to 25.34 in late trade.

The worst performers of the session were First Majestic Silver Corp. (TSX:AG), which fell 4.24% or 0.93 points to trade at 20.98 at the close. Ivanhoe Mines Ltd. (TSX:IVN) declined 3.40% or 0.53 points to end at 15.08 and Aya Gold & Silver Inc (TSX:AYA) was down 3.14% or 0.59 points to 18.21.

Rising stocks outnumbered declining ones on the Toronto Stock Exchange by 485 to 403 and 88 ended unchanged.

The S&P/TSX 60 VIX, which measures the implied volatility of S&P/TSX Composite options, was down 13.20% to 11.57.

Gold Futures for February delivery was up 0.15% or 6.30 to $4,238.80 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in January rose 1.41% or 0.83 to hit $59.78 a barrel, while the February Brent oil contract rose 1.12% or 0.70 to trade at $63.37 a barrel.

CAD/USD was unchanged 0.07% to 0.72, while CAD/EUR unchanged 0.18% to 0.62.

The US Dollar Index Futures was up 0.24% at 99.04.

Investing.com – Colombia stocks were higher after the close on Thursday, as gains in the Industrials, Services and Agriculture sectors led shares higher.

At the close in Colombia, the COLCAP rose 0.49% to hit a new all time high.

The best performers of the session on the COLCAP were Bolsa De Valores De Colombia (BVC:BVC), which rose 1.30% or 180.00 points to trade at 14,080.00 at the close. Meanwhile, Ecopetrol SA (BVC:ECO) added 1.06% or 20.00 points to end at 1,910.00 and Organizacion Terpel SA (BVC:TPL) was up 1.04% or 180.00 points to 17,480.00 in late trade.

The worst performers of the session were Grupo de Inversiones Suramericana SA Preferred (BVC:SIS_p), which fell 1.95% or 900.00 points to trade at 45,180.00 at the close. Interconnection Electric SA ESP (BVC:ISA) declined 1.71% or 440.00 points to end at 25,300.00 and Bancolombia Pf (BVC:BIC_p1) was down 1.57% or 960.00 points to 60,300.00.

Rising stocks outnumbered declining ones on the Colombia Stock Exchange by 1 to 0.

Shares in Organizacion Terpel SA (BVC:TPL) rose to 5-year highs; rising 1.04% or 180.00 to 17,480.00.

US coffee C for March delivery was up 1.70% or 6.35 to $378.80 . Elsewhere in commodities trading, US cocoa for delivery in March fell 0.15% or 8.00 to hit $5,496.00 , while the February Gold Futures contract rose 0.17% or 7.00 to trade at $4,239.50 a troy ounce.

USD/COP was up 0.89% to 3,804.00, while BRL/COP rose 0.77% to 716.92.

The US Dollar Index Futures was up 0.23% at 99.02.

Investing.com -- Vanda Pharmaceuticals (NASDAQ:VNDA) stock rose 11% in after-hours trading on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on its tradipitant protocol for motion sickness treatment.

The FDA’s decision removes previous limitations that restricted the protocol VP-VLY-686-3403 to a maximum of 90 doses of tradipitant. The agency agreed with Vanda’s position that motion sickness represents an acute, self-limiting physiologic response rather than a chronic condition, eliminating the need for an additional six-month dog toxicity study.

This regulatory development allows Vanda to extend clinical studies of tradipitant in motion sickness. The resolution followed Vanda’s formal dispute resolution request and an expedited re-review conducted by FDA leadership under a collaborative framework established between the company and the agency in October 2025.

Separately, Vanda confirmed that the review of its New Drug Application for tradipitant for the prevention of motion-induced vomiting remains on track with a PDUFA target action date of December 30, 2025. If approved, tradipitant would be the first new pharmacologic treatment for motion sickness in over 40 years.

Mihael H. Polymeropoulos, President and CEO of Vanda, stated that "The swift and favorable resolution of this issue highlights the effectiveness of our collaborative framework with the FDA."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- SoFi Technologies (NASDAQ:SOFI) stock fell 5% in after-hours trading Thursday after the company announced a $1.5 billion public offering of common stock.

The fintech company said all shares in the offering will be sold by SoFi, and it plans to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares offered.

SoFi intends to use the net proceeds from the offering for general corporate purposes, including enhancing its capital position, increasing optionality, enabling more efficient capital management, and funding incremental growth and business opportunities.

The announcement comes as SoFi continues to expand its financial services platform, which includes lending, banking, and investment products. The company has been working to strengthen its financial position amid a competitive landscape in the digital banking sector.

This capital raise could provide SoFi with additional resources to pursue its growth strategy, though the stock issuance may lead to dilution for existing shareholders, which likely contributed to the negative market reaction in after-hours trading.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.